Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Will Simpler Devices Tap the Largest Diabetes Market?

This article was originally published in Start Up

Executive Summary

The clinical community and the medical device industry are finally turning their attention to the majority of patients with diabetes: the type 2s. They're an underserved group in a potential market that dwarfs that of type 1 diabetes. Health Advances LLC believes that the next disruptive technology in diabetes management will come in the form of lower-cost, easy-to-use insulin pumps for the masses. And there are at least 16 such pumps in development. (See also the sidebar, CeQur: Conforming to the Lifesyle of the Type 2).

Related Content

Valeritas Raises $150 Million In Series C Round
At Last: Insulin Delivery Devices for the Bulk of the Diabetes Population
The A-List: 2009's Trend-Shaping Series A Financings
SmartCells Inc.
The Top Device Stories of 2008
Diabetes: CGM Goes Mainstream
Inhaled Insulin is Dead. Long Live Inhaled Insulin
Inhaled Insulin is Dead. Long Live Inhaled Insulin
Insulin Delivery: Still Waiting to Exhale
Exubera's Problem: It's Still Just Insulin


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts